Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ODM-212 in Advanced Solid Tumours
NCT06725758Phase 2Recruiting
- Sponsor
- Orion Corporation
- Start
- Oct 2023
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of ODM-212 in solid tumor, sponsored by Orion Corporation. Started Oct 2023; status: recruiting.
02
Drugs
ODM-212
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT06725758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06725758.